Ironwood Pharmaceuticals, Inc. - Class A (IRWD) is a publicly traded Healthcare sector company. As of July 15, 2026, IRWD trades at $3.97 with a market cap of $693.02M and a P/E ratio of 6.21. IRWD moved -5.23% today. Year to date, IRWD is +18.10%; over the trailing twelve months it is +439.22%. Its 52-week range spans $0.53 to $5.78. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces IRWD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for IRWD, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $3.97 |
| Market Cap | $693.02M |
| P/E Ratio | 6.21 |
| EPS | $0.64 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.78 |
| 52-Week Low | $0.53 |
| Volume | 1.79M |
| Avg Volume | 0 |
| Revenue (TTM) | $361.51M |
| Net Income | $102.18M |
| Gross Margin | 0.00% |
2 analysts cover IRWD: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.